{
    "id": "5ccce999-8201-4354-9f59-beac382f00bb",
    "indications": "Kaitlib Fe is a combination of norethindrone, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) The efficacy in females of reproductive potential with a body mass index (BMI) of >35 kg/m 2 has not been evaluated. ( 1 , 8.8 )",
    "contraindications": "Chew one tablet without water at the same time every day. ( 2.1 ) Take tablets in the order directed on the blister pack. ( 2.1 )",
    "warningsAndPrecautions": "Kaitlib Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) is available in a blister containing 28 tablets (NDC 68180-903-71). Each blister is packed in a pouch (NDC 68180-903-71) and three such pouches are packed in a carton (NDC 68180-903-73).\n                        Each blister (28 tablets) contains in the following order:\n                        \n                           24 light green, round flat face beveled edged tablets      (active) debossed with \"I61\" on one side and \"LU\" on the other      side each containing 0.8 mg norethindrone and 0.025 mg ethinyl estradiol.\n                           4 brown mottled, round, flat face beveled edge tablets      (non-hormonal placebo) debossed with \"LU\" on one side and \"I62\"      on the other side and each containing 75 mg ferrous fumarate.",
    "adverseReactions": "A high risk of arterial or venous thrombotic diseases. ( 4 ) Undiagnosed abnormal uterine bleeding. ( 4 ) Breast cancer. ( 4 ) Liver tumors or liver disease. ( 4 ) Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( 4 )",
    "ingredients": [],
    "organization": "Lupin Pharmaceuticals, Inc.",
    "name": "Kaitlib Fe",
    "effectiveTime": "20250521"
}